卡德14信号酶的形成与其内体转移和mTORC1诱导的角质细胞增殖有关
Paul A O'Sullivan1,2, Aigerim Aidarova3, Inna S Afonina3
1The Francis Crick Institute, London NW1 1AT, U.K.
The Biochemical journal
|August 15, 2024
概括
罕见的CARD14突变通过激活免疫路径驱动牛皮. 针对mTORC1与拉巴胺减少了小鼠的角质细胞增殖和表皮厚化,为CARD14依赖的牛皮提供了潜在的治疗策略.
科学领域:
- 免疫学 免疫学 免疫学
- 皮肤病学 皮肤病学
- 分子生物学分子生物学
背景情况:
- 罕见的CARD14突变与牛皮的发展有关.
- 通过CARD14-BCL10-MALT1复合体,CARD14突变通过激活核因子-卡帕B (NF-κB) 和基激活蛋白 (MAP) 激酶来促进牛皮.
- CARD14突变的特定下游信号机制需要进一步阐明.
研究的目的:
- 为了阐明 CARD14E138A 突变的下游信号机制.
- 为了研究蛋白相互作用和在CARD14中介信号传递中的泛化作用.
- 探索针对mTORC1在CARD14依赖性牛皮的潜在治疗影响.
主要方法:
- 同免疫沉测试以确定蛋白质相互作用.
- 乌比基化试验用于评估蛋白质修饰.
- 免疫光显微镜以确定蛋白质定位.
- 在体内小鼠模型中评估治疗疗效.
主要成果:
- CARD14E138A与HOIP和TRAF6相互作用,促进了NF-κB和MAP激酶激活所必需的BCL10无化.
- A20和ABIN1通过诱导其周转来负面调节CARD14E138A信号.
- CARD14E138A定位在早期的内分体中,需要AP2复合体来激活mTORC1,刺激质细胞代谢.
- 在小鼠中,拉巴胺治疗改善了CARD14E138A诱导的角质细胞增殖和表皮性阿坎索斯.
结论:
- CARD14E138A突变激活了不同的信号通路,包括NF-κB,MAP激酶和mtORC1.
- 在调节 CARD14 信号传递方面,ubiquitination 和 deubiquitination 过程起着至关重要的作用.
- 针对mTORC1代表了对CARD14依赖性牛皮的有前途的治疗策略.
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
MAPK Signaling Cascades
5.3K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.3K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Assembly of Signaling Complexes
5.7K
Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
5.7K
M-Cdk Drives Transition Into Mitosis
5.5K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.5K


